Cargando…

Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique

OBJECTIVES: Atrophic rhinitis (AR) and empty nose syndrome (ENS) are chronic diseases characterized by a paradoxical nasal obstruction. These rare syndromes tend to occur after nasal surgery of the inferior turbinates in ENS and can be idiopathic in AR. Medical treatments alone are often insufficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Charles‐Henri, Malheiro, Emeline, Béquignon, Emilie, Coste, André, Bartier, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823167/
https://www.ncbi.nlm.nih.gov/pubmed/35155777
http://dx.doi.org/10.1002/lio2.713
_version_ 1784646745973587968
author Hassan, Charles‐Henri
Malheiro, Emeline
Béquignon, Emilie
Coste, André
Bartier, Sophie
author_facet Hassan, Charles‐Henri
Malheiro, Emeline
Béquignon, Emilie
Coste, André
Bartier, Sophie
author_sort Hassan, Charles‐Henri
collection PubMed
description OBJECTIVES: Atrophic rhinitis (AR) and empty nose syndrome (ENS) are chronic diseases characterized by a paradoxical nasal obstruction. These rare syndromes tend to occur after nasal surgery of the inferior turbinates in ENS and can be idiopathic in AR. Medical treatments alone are often insufficient. Surgical options are challenging and numerous resorbable and nonresorbable implants have been described in small series, with as many surgical techniques described. Whereas current surgical procedures are for risk of extrusions, graft rejections or poor lasting results, the use of GlassBONE™ (Sodimed®, Avignon, France), a bioactive glass, for a vestibular approach in AR and ENS has never been reported for this indication. METHODS: We described an original technique of nasal submucoperiosteal bilateral ceramic glass implantation in two patients with AR and ENS. RESULTS: The two cases presented a postoperative satisfying endoscopic and sinus CT‐scan results with filling of the nasal cavities, with less crusts and a complete wound healing. They had no short‐term complications. CONCLUSION: This innovative approach is easily feasible and could be an option considered for the surgical management of AR and ENS. Level of evidence: 4.
format Online
Article
Text
id pubmed-8823167
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-88231672022-02-11 Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique Hassan, Charles‐Henri Malheiro, Emeline Béquignon, Emilie Coste, André Bartier, Sophie Laryngoscope Investig Otolaryngol Allergy, Rhinology, and Immunology OBJECTIVES: Atrophic rhinitis (AR) and empty nose syndrome (ENS) are chronic diseases characterized by a paradoxical nasal obstruction. These rare syndromes tend to occur after nasal surgery of the inferior turbinates in ENS and can be idiopathic in AR. Medical treatments alone are often insufficient. Surgical options are challenging and numerous resorbable and nonresorbable implants have been described in small series, with as many surgical techniques described. Whereas current surgical procedures are for risk of extrusions, graft rejections or poor lasting results, the use of GlassBONE™ (Sodimed®, Avignon, France), a bioactive glass, for a vestibular approach in AR and ENS has never been reported for this indication. METHODS: We described an original technique of nasal submucoperiosteal bilateral ceramic glass implantation in two patients with AR and ENS. RESULTS: The two cases presented a postoperative satisfying endoscopic and sinus CT‐scan results with filling of the nasal cavities, with less crusts and a complete wound healing. They had no short‐term complications. CONCLUSION: This innovative approach is easily feasible and could be an option considered for the surgical management of AR and ENS. Level of evidence: 4. John Wiley & Sons, Inc. 2021-12-08 /pmc/articles/PMC8823167/ /pubmed/35155777 http://dx.doi.org/10.1002/lio2.713 Text en © 2021 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Allergy, Rhinology, and Immunology
Hassan, Charles‐Henri
Malheiro, Emeline
Béquignon, Emilie
Coste, André
Bartier, Sophie
Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique
title Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique
title_full Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique
title_fullStr Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique
title_full_unstemmed Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique
title_short Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique
title_sort sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: operative technique
topic Allergy, Rhinology, and Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823167/
https://www.ncbi.nlm.nih.gov/pubmed/35155777
http://dx.doi.org/10.1002/lio2.713
work_keys_str_mv AT hassancharleshenri sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique
AT malheiroemeline sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique
AT bequignonemilie sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique
AT costeandre sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique
AT bartiersophie sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique